Viking Therapeutics, Inc — gráfico, cotizaciones y noticias (NASDAQ:VKTX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Market Capitalization 4.11 B
Employee 53
Founded 2012
CEO Brian Lian
Website www.vikingtherapeutics.com
Headquarter Delaware, United States
FIGI BBG006LGV869
Industry Technology

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

4.11 B Capitalización de mercado

Noticias

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing

NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?

LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships

3 Best Stocks Under $50 to Buy in April 2026, According to Analysts - TipRanks.com

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks

VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug

Morgan Stanley reitera calificación de Viking Therapeutics por avances en ensayos

Viking Therapeutics completa la inscripción en ensayo de fármaco para obesidad

LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D